Please login to the form below

Not currently logged in
Email:
Password:

Amgen’s Anna Richo joins UCB as executive VP and general counsel

Meanwhile, Cynthia Patton takes over as Amgen’s senior VP and chief compliance officer

Anna Richo UCBAnna Richo will leave Amgen to join UCB as the Belgian biopharma company's new executive VP and general counsel.

Richo (pictured) is currently senior VP and chief compliance officer at Amgen, a role that will be taken over by Cynthia Patton from October 22.

In her new position at UCB, Richo will become a member of the company's executive committee and report directly to the CEO Roch Doliveux. She succeeds Bob Trainor, who retires at the end of the year after six years in the role.

"I am very happy to welcome Anna's wealth of legal and leadership qualities, which will be a great natural fit with the global teams Bob has led, as well as with UCB's ongoing journey to becoming the patient-centric global biopharma leader," said Doliveux.

"At the same time it is with immense appreciation and regret that we say goodbye to Bob, who has been instrumental in driving UCB's transformation."

Richo has been in her current position since 2008, having spent the previous five years serving as VP law, responsible for managing the company's corporate litigation and law department operations.

Prior to joining Amgen, she spent 12 years at Baxter Healthcare where she held several law-related positions, eventually becoming VP law for Baxter BioScience.

Her replacement at Amgen, Patton, is promoted from a role as VP in the company's law department, with responsibility for commercial legal activities in the US.

Previously, Patton served as the lead commercial lawyer for both Amgen's oncology and inflammation business units.

17th October 2012

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...